Elvie raises £9.6m from existing backers to support women's health technology.
The London-based femtech company secures fresh capital from its current investor base.
Elvie develops consumer technology products for women's health, including wearable breast pumps and pelvic floor trainers.
London-based femtech startup Elvie has secured £9.6m in a funding round backed by existing investors.
Founded in 2013, the company focuses on creating sleek consumer health products for women, such as its silent wearable breast pumps and app-connected pelvic floor trainers. The latest capital injection follows a £70.7m Series C round in 2021 and a £18.5m internal funding extension in 2022.
Elvie has previously attracted backing from institutional investors including BlackRock, Octopus Ventures, and the Business Growth Fund, bringing its total funding to $136m.